How To Manage Extravasation Of Ibandronic Acid?: A Case Report

Authors : Ender SALBAŞ, Ali Yavuz KARAHAN, Levent TEKİN, Banu ORDAHAN, Sertaç KETENCİ

Pages : 68-70

Doi:10.33713/egetbd.433179

View : 22 | Download : 11

Publication Date : 2018-09-10

Article Type : Other Papers

Abstract :Ibandronic acid (IA) is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis. It may also be used to treat hypercalcemia (elevated blood calcium levels). Arthralgia, femur fracture, pain in extremity, diarrhea, myalgia, nausea, back pain, pain, and bone pain are most common adverse events of the IA reported to the FDA. We discourse a case of IA extravasation in this presentation. An osteoporotic woman who was using bifosfonate medications had applied intravenous IA, but almost all of the solution was extravasated accidentally. Two hours later she noticed burning and moderate itching sensation and slight millimeter erythema at the flexure of the right elbow in the region of venipuncture but she had decided not to inform. Although the day after the erythematous area had increased to 5-6 cm and the symptoms worsened, she revisited the outcome clinic. Also, she had a complaint of vomiting and diarrhea. Also, we want to discuss the question of “How this patient's osteoporosis treatment should be continued after this situation?”
Keywords : Extravasation, ibandronic acid, management, prevention